Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,OR[95%CI],P_value
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ABCA2,ATP-binding cassette sub-family A member 2,17001,51,2.99 [1.78-5.04],3.677504771461037e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ABL1,Tyrosine-protein kinase ABL1,20108,81,1.74 [1.35-2.24],2.3117274987220907e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",19761,80,1.37 [1.10-1.71],0.0043610155217675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACAN,Aggrecan core protein,20011,82,4.15 [2.07-8.33],6.033749825031265e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACE,Angiotensin-converting enzyme,17611,51,5.06 [2.61-9.82],1.624887075003598e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACE2,Angiotensin-converting enzyme 2,19823,80,1.54 [1.14-2.06],0.0042514257903517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACHE,Acetylcholinesterase,17227,49,2.57 [1.34-4.94],0.0045842117282732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACP5,Tartrate-resistant acid phosphatase type 5,20316,83,2.86 [1.91-4.28],3.225856014022607e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACP6,Lysophosphatidic acid phosphatase type 6,20337,81,1.76 [1.27-2.44],0.0006590002031311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACRV1,Acrosomal protein SP-10,17083,52,1.64 [1.38-1.95],1.7634668569197183e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACTA2,"Actin, aortic smooth muscle",19823,80,3.02 [2.44-3.75],7.941750014897081e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACTN2,Alpha-actinin-2,17001,51,2.03 [1.49-2.78],8.234625919255458e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADA,Adenosine deaminase,20408,82,2.56 [1.68-3.91],1.2614403479477647e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADA2,Adenosine deaminase 2,20127,82,7.85 [5.60-11.02],8.761903092432266e-33
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,17083,52,6.83 [4.47-10.44],6.204515802733334e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,20021,81,8.09 [5.02-13.03],8.710390534758626e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,20408,82,8.85 [4.55-17.20],1.2576312239039665e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,20329,81,3.11 [1.94-4.98],2.4095072564610803e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,17522,52,6.99 [4.11-11.89],6.835474841885307e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,17083,52,2.43 [1.51-3.91],0.0002585251020232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,20108,81,2.59 [1.67-4.02],2.112687107477372e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,19823,80,2.04 [1.57-2.64],8.106157175320743e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,17083,52,2.54 [1.46-4.41],0.0009613370987272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,20289,81,2.01 [1.28-3.15],0.0024181783498117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAMTSL2,ADAMTS-like protein 2,17614,50,3.66 [2.03-6.60],1.6205050509222447e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADGRB3,Adhesion G protein-coupled receptor B3,19986,81,9.21 [5.48-15.49],5.3243923803399455e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADGRD1,Adhesion G-protein coupled receptor D1,17227,49,4.20 [2.38-7.41],7.618515244744512e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADGRE1,Adhesion G protein-coupled receptor E1,17522,52,2.00 [1.36-2.96],0.0004961004195166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADGRE5,Adhesion G protein-coupled receptor E5,20375,83,5.53 [3.73-8.21],1.7569428415807418e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADGRG1,Adhesion G-protein coupled receptor G1,20108,81,2.21 [1.90-2.56],3.751012802593033e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AFP,Alpha-fetoprotein,19951,81,0.28 [0.20-0.39],1.0135051834595461e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AGER,Advanced glycosylation end product-specific receptor,20166,79,2.26 [1.48-3.43],0.0001427189750471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AGR2,Anterior gradient protein 2 homolog,19585,75,1.95 [1.65-2.32],1.1116587516856135e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AGR3,Anterior gradient protein 3,19719,80,1.77 [1.35-2.32],3.630170333189847e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AGRN,Agrin,20290,80,6.77 [4.87-9.42],6.012766619052881e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AGRP,Agouti-related protein,20408,82,2.26 [1.64-3.12],7.281486883018014e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AHNAK,Neuroblast differentiation-associated protein AHNAK,17158,52,2.65 [1.51-4.64],0.0006595159510249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AHNAK2,Protein AHNAK2,17158,52,4.48 [2.68-7.48],1.0840062017966242e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",20077,81,1.33 [1.11-1.59],0.0017917893964444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AKR1C4,Aldo-keto reductase family 1 member C4,19823,80,1.43 [1.11-1.86],0.0064431663307024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ALCAM,CD166 antigen,20456,83,5.28 [2.29-12.15],9.10363187263198e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AMIGO2,Amphoterin-induced protein 2,20108,81,3.69 [1.63-8.35],0.0017099660968627
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,16475,49,0.37 [0.20-0.68],0.0013814427190267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANG,Angiogenin,20192,82,4.12 [2.70-6.30],6.000740994103471e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANGPT2,Angiopoietin-2,20371,81,4.70 [3.20-6.92],3.778028323852466e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANGPTL1,Angiopoietin-related protein 1,19930,81,4.01 [2.08-7.71],3.196212663466613e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANGPTL3,Angiopoietin-related protein 3,20250,82,0.47 [0.29-0.77],0.0029441444783973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANGPTL4,Angiopoietin-related protein 4,20254,80,8.70 [5.62-13.45],2.3150470376447813e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANGPTL7,Angiopoietin-related protein 7,20371,81,3.53 [2.32-5.38],3.6361934115948565e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANPEP,Aminopeptidase N,20306,82,2.73 [1.53-4.87],0.0006784696920281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANXA10,Annexin A10,19753,77,1.41 [1.15-1.72],0.0008040910293666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANXA5,Annexin A5,19689,77,3.86 [2.50-5.97],1.2529137049247723e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AOC1,Amiloride-sensitive amine oxidase [copper-containing],19834,81,1.39 [1.12-1.72],0.0023111786091945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AP1G2,AP-1 complex subunit gamma-like 2,17526,51,1.50 [1.11-2.01],0.0076371207978654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,20108,81,1.71 [1.23-2.38],0.0013236752611586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",APCS,Serum amyloid P-component,17468,50,0.38 [0.20-0.73],0.0035207173501846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",APOA2,Apolipoprotein A-II,17611,51,1.91 [1.17-3.12],0.0094199405858054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",APOA4,Apolipoprotein A-IV,17637,50,3.69 [2.66-5.12],6.529359752269451e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",APOC1,Apolipoprotein C-I,17607,50,0.11 [0.06-0.21],2.0937405382279955e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",APOD,Apolipoprotein D,16888,46,0.23 [0.09-0.57],0.0015783586404175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",APOE,Apolipoprotein E,17637,50,0.31 [0.18-0.54],3.117112231812636e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",APOH,Beta-2-glycoprotein 1,20222,80,1.91 [1.21-3.03],0.005689865161637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",APOL1,Apolipoprotein L1,17611,51,0.32 [0.20-0.51],1.715373903984435e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",APOM,Apolipoprotein M,20287,82,0.10 [0.06-0.18],7.387367161549059e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AREG,Amphiregulin,20108,81,3.74 [2.84-4.92],5.681818158574623e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ARG1,Arginase-1,20075,80,0.49 [0.34-0.72],0.0002511140987187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ARHGEF10,Rho guanine nucleotide exchange factor 10,17572,52,1.46 [1.12-1.92],0.0053518107539472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ART3,Ecto-ADP-ribosyltransferase 3,20332,82,6.97 [4.61-10.53],3.1392098102810894e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ASGR1,Asialoglycoprotein receptor 1,20021,81,8.13 [5.10-12.95],1.2775569021740941e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ASGR2,Asialoglycoprotein receptor 2,17611,51,7.55 [3.62-15.76],7.161644703731408e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ATOX1,Copper transport protein ATOX1,20289,81,1.74 [1.28-2.37],0.0003775780613235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ATP6AP2,Renin receptor,19761,80,1.72 [1.23-2.41],0.0016572746452639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ATRAID,All-trans retinoic acid-induced differentiation factor,17522,52,4.13 [2.90-5.89],4.7087958505833684e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AXL,Tyrosine-protein kinase receptor UFO,20332,82,7.49 [4.20-13.36],8.982107308564246e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",B2M,Beta-2-microglobulin,17637,50,2.29 [1.68-3.14],2.24125457192374e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BAG3,BAG family molecular chaperone regulator 3,19986,81,2.09 [1.27-3.44],0.0038461562147735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,19761,80,1.54 [1.19-1.99],0.0010333022140624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BAMBI,BMP and activin membrane-bound inhibitor homolog,19761,80,6.34 [4.31-9.32],6.591074525898645e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BCAM,Basal cell adhesion molecule,20222,80,3.93 [2.21-7.00],3.2934188841762603e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BCAN,Brevican core protein,20021,81,0.36 [0.21-0.63],0.0002903680682869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",20157,80,4.75 [2.70-8.34],6.128520482674171e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BCL2L15,Bcl-2-like protein 15,17083,52,1.75 [1.28-2.39],0.0004329032018463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BMP4,Bone morphogenetic protein 4,19986,81,1.98 [1.39-2.83],0.0001601562614597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,17083,52,2.25 [1.39-3.64],0.0009642765981128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BOLA1,BolA-like protein 1,17030,52,1.68 [1.18-2.41],0.0043845435518336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BPIFB1,BPI fold-containing family B member 1,20157,82,0.67 [0.51-0.89],0.0060296065967259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BRK1,Protein BRICK1,19753,77,2.19 [1.49-3.22],6.196683389351392e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BST2,Bone marrow stromal antigen 2,20368,81,1.51 [1.14-2.00],0.004048936095062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BTN3A2,Butyrophilin subfamily 3 member A2,20157,80,2.89 [2.13-3.91],7.239858621710431e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",C1QA,Complement C1q subcomponent subunit A,20314,82,8.28 [4.24-16.17],6.056501677028583e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,20332,82,2.76 [1.95-3.92],1.2353297367215848e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,17227,49,3.25 [1.64-6.45],0.0007663145592902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,17572,52,2.09 [1.26-3.47],0.0043473793307558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",C1RL,Complement C1r subcomponent-like protein,17603,50,6.40 [1.78-23.06],0.0045059836327074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",C2,Complement C2,20287,82,8.42 [3.15-22.51],2.177577573877401e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CA14,Carbonic anhydrase 14,20371,81,4.86 [3.08-7.65],9.466702589023315e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CA3,Carbonic anhydrase 3,20423,83,2.25 [1.72-2.95],2.858426140593023e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CA4,Carbonic anhydrase 4,20456,83,9.36 [4.32-20.24],1.3570004462325e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CA5A,"Carbonic anhydrase 5A, mitochondrial",19823,80,1.53 [1.28-1.83],2.929816484639198e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CA9,Carbonic anhydrase 9,20371,81,2.50 [1.86-3.37],1.3827694729356167e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CALB1,Calbindin,20108,81,3.17 [2.28-4.42],8.205563131144564e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CALB2,Calretinin,19753,77,1.64 [1.26-2.15],0.0002516900140874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CALCA,Calcitonin,19988,80,1.83 [1.52-2.21],3.3769717977346127e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CALCB,Calcitonin gene-related peptide 2,17573,52,2.34 [1.71-3.20],1.2754569107214824e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CANT1,Soluble calcium-activated nucleotidase 1,20136,82,6.87 [2.74-17.20],3.856325061749725e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CAPG,Macrophage-capping protein,20026,79,1.61 [1.19-2.19],0.0021970032011917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CBLIF,Cobalamin binding intrinsic factor,20167,82,1.43 [1.13-1.82],0.0033349680319017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCDC80,Coiled-coil domain-containing protein 80,20208,82,4.63 [3.23-6.62],5.807874877064496e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,17158,52,2.21 [1.59-3.08],2.8249833163230733e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL11,Eotaxin,20408,82,4.42 [2.64-7.38],1.4157224203795872e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL14,C-C motif chemokine 14,20192,82,2.52 [1.83-3.48],1.6893309027508894e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL15,C-C motif chemokine 15,20456,83,5.61 [4.02-7.82],2.8193340495628955e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL16,C-C motif chemokine 16,20456,83,2.10 [1.45-3.04],9.407819671389318e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL20,C-C motif chemokine 20,20408,82,1.32 [1.11-1.57],0.0020095680648399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL21,C-C motif chemokine 21,20290,80,2.16 [1.72-2.71],3.940251525816327e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL25,C-C motif chemokine 25,20408,82,4.74 [3.32-6.76],1.005183177474788e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL3,C-C motif chemokine 3,20157,80,1.30 [1.07-1.57],0.0070446340653602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL7,C-C motif chemokine 7,20157,80,1.51 [1.16-1.96],0.0019396438791504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCN3,CCN family member 3,20424,83,8.02 [5.66-11.36],1.2408453528872201e-31
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCN4,CCN family member 4,20371,81,5.40 [3.76-7.76],6.944446563066151e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCS,Copper chaperone for superoxide dismutase,20021,81,0.55 [0.36-0.85],0.0076797009070971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD109,CD109 antigen,20222,80,5.49 [3.05-9.90],1.4528305439898712e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD14,Monocyte differentiation antigen CD14,19846,82,3.77 [2.53-5.62],6.977136876232011e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD160,CD160 antigen,20408,82,4.52 [3.39-6.03],8.98642340459313e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD163,Scavenger receptor cysteine-rich type 1 protein M130,20332,82,3.35 [2.30-4.87],2.6442922044533427e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD164,Sialomucin core protein 24,20222,80,2.23 [1.66-2.99],9.646666527702604e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD1C,T-cell surface glycoprotein CD1c,20289,81,0.30 [0.15-0.61],0.0007779086981414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD200,OX-2 membrane glycoprotein,20157,80,3.47 [2.09-5.78],1.6720567341304818e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD207,C-type lectin domain family 4 member K,19748,79,6.24 [4.17-9.33],5.28031523580689e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD244,Natural killer cell receptor 2B4,20408,82,3.70 [1.98-6.92],4.2547503836513205e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD27,CD27 antigen,20289,81,6.76 [5.04-9.07],2.936278544407444e-37
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD274,Programmed cell death 1 ligand 1,20021,81,4.11 [2.94-5.74],1.1132937675610845e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD28,T-cell-specific surface glycoprotein CD28,19761,80,2.48 [1.84-3.34],1.980489268235085e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD300A,CMRF35-like molecule 8,17227,49,9.10 [4.78-17.33],1.7901364596934404e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD300C,CMRF35-like molecule 6,20368,81,7.19 [4.69-11.04],1.8778317399654121e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD300E,CMRF35-like molecule 2,20304,81,5.02 [3.66-6.87],1.1447218980146822e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD300LF,CMRF35-like molecule 1,20371,81,2.49 [1.77-3.51],1.7851090421475589e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD300LG,CMRF35-like molecule 9,20222,80,3.55 [2.23-5.64],8.929222402530194e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD302,CD302 antigen,20108,81,9.04 [6.13-13.32],9.0111166697768e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD4,T-cell surface glycoprotein CD4,20124,79,2.69 [1.95-3.71],1.835900566798649e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD40,Tumor necrosis factor receptor superfamily member 5,20196,80,2.92 [2.11-4.05],1.363277639807371e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD46,Membrane cofactor protein,20129,82,7.72 [5.14-11.58],5.736083463471955e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD48,CD48 antigen,20254,80,7.14 [4.44-11.47],4.427265192033483e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD5,T-cell surface glycoprotein CD5,20335,81,2.59 [1.92-3.49],3.8634324416570317e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD55,Complement decay-accelerating factor,19538,80,7.67 [5.04-11.69],2.2550833969156602e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD58,Lymphocyte function-associated antigen 3,20173,79,5.18 [1.69-15.83],0.0039296391655689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD7,T-cell antigen CD7,17043,51,2.75 [1.92-3.94],3.0917632685651354e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD70,CD70 antigen,20157,80,2.02 [1.34-3.06],0.0008213327121543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD72,B-cell differentiation antigen CD72,17227,49,2.68 [1.72-4.18],1.3061576595276596e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD74,HLA class II histocompatibility antigen gamma chain,20368,81,8.27 [5.62-12.16],8.679842500153706e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD79B,B-cell antigen receptor complex-associated protein beta chain,20408,82,4.06 [3.22-5.11],1.384261085338373e-32
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD80,T-lymphocyte activation antigen CD80,17610,52,4.42 [2.72-7.19],2.163451721692654e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD83,CD83 antigen,20157,80,5.21 [3.43-7.91],9.052238477931372e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD93,Complement component C1q receptor,19469,79,8.86 [5.46-14.39],1.1167827663788771e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD99L2,CD99 antigen-like protein 2,20222,80,6.68 [3.39-13.18],4.178894061187142e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDCP1,CUB domain-containing protein 1,20021,81,1.58 [1.14-2.19],0.0056682464564698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDH1,Cadherin-1,19584,81,3.89 [3.09-4.91],1.4288461432768051e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDH15,Cadherin-15,20335,80,2.27 [1.88-2.75],2.390805611418118e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDH17,Cadherin-17,20208,82,2.10 [1.65-2.67],1.6731920749272252e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDH2,Cadherin-2,20208,82,3.23 [1.90-5.51],1.6218900079070554e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDH3,Cadherin-3,20368,81,5.37 [3.74-7.70],6.207230625372693e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDH6,Cadherin-6,20208,82,4.10 [2.71-6.23],3.123662636086948e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDHR5,Cadherin-related family member 5,20208,82,0.54 [0.34-0.85],0.00733757964642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDKN1A,Cyclin-dependent kinase inhibitor 1,20108,81,1.32 [1.09-1.59],0.0039601718490842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDNF,Cerebral dopamine neurotrophic factor,20108,81,3.85 [2.58-5.76],4.209047948112911e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDSN,Corneodesmosin,20350,81,3.39 [2.28-5.03],1.685317306770472e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,17522,52,2.36 [1.41-3.97],0.0011031184321559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,20157,80,1.38 [1.11-1.70],0.0035217594419815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,19823,80,2.15 [1.56-2.97],2.8264666993433604e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CELA2A,Chymotrypsin-like elastase family member 2A,17614,50,0.31 [0.22-0.44],1.449330086502116e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CELA3A,Chymotrypsin-like elastase family member 3A,20425,83,0.42 [0.30-0.57],4.0668454253918855e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,17227,49,5.41 [2.97-9.84],3.2235024043322114e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CEP20,Centrosomal protein 20,19761,80,1.48 [1.16-1.90],0.001856750637676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CES1,Liver carboxylesterase 1,20272,82,0.68 [0.53-0.87],0.0021983249419523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CFD,Complement factor D,17637,50,5.25 [2.39-11.50],3.497914334506094e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CFHR2,Complement factor H-related protein 2,17506,49,2.29 [1.26-4.17],0.0065160582504623
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CGREF1,Cell growth regulator with EF hand domain protein 1,20208,82,8.03 [5.46-11.82],4.5561753298570856e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",17573,52,4.09 [2.97-5.62],4.5941544381144826e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CHCHD6,MICOS complex subunit MIC25,17526,51,2.46 [1.49-4.06],0.0004162497664246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CHGA,Chromogranin-A,17614,50,1.67 [1.38-2.02],1.364190173323759e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CHGB,Secretogranin-1,20306,80,4.36 [3.13-6.08],3.910795453192599e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CHI3L1,Chitinase-3-like protein 1,19817,80,1.57 [1.29-1.91],6.725989739985806e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CILP,Cartilage intermediate layer protein 1,17614,50,7.12 [4.45-11.38],2.5275236112530933e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CKAP4,Cytoskeleton-associated protein 4,20321,82,9.76 [6.64-14.33],3.336541165140066e-31
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CKB,Creatine kinase B-type,17614,50,3.90 [2.59-5.87],7.621512249986345e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLC,Galectin-10,20172,82,1.84 [1.47-2.31],1.5488940822912985e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLEC10A,C-type lectin domain family 10 member A,20021,81,2.45 [1.44-4.15],0.0008892544295408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLEC12A,C-type lectin domain family 12 member A,17083,52,3.48 [1.57-7.70],0.0020987042830918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLEC1A,C-type lectin domain family 1 member A,19823,80,6.51 [4.23-9.99],1.2421916301991636e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLEC4D,C-type lectin domain family 4 member D,20157,80,2.30 [1.73-3.04],6.998950070086322e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLEC5A,C-type lectin domain family 5 member A,20151,82,4.70 [2.87-7.69],7.15045509984765e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLEC6A,C-type lectin domain family 6 member A,19761,80,2.05 [1.45-2.91],5.449595694213062e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLEC7A,C-type lectin domain family 7 member A,20408,82,4.82 [3.30-7.05],4.987797589181396e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",19988,80,1.31 [1.07-1.60],0.0096507274251368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLSTN2,Calsyntenin-2,20408,82,2.62 [1.80-3.80],4.0355591769600523e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CNTN1,Contactin-1,20456,83,4.54 [2.35-8.77],6.5759796578388544e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CNTN2,Contactin-2,20371,81,2.28 [1.51-3.45],8.803161148326842e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CNTN3,Contactin-3,20222,80,2.46 [1.31-4.60],0.0050636974505503
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CNTN4,Contactin-4,20222,80,6.45 [3.04-13.66],1.1446826136589766e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CNTNAP2,Contactin-associated protein-like 2,20157,80,2.46 [1.69-3.57],2.4002113301206435e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",COL15A1,Collagen alpha-1(XV) chain,17614,50,4.50 [2.26-8.95],1.788007868679111e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",COL2A1,Collagen alpha-1(II) chain,17158,52,1.63 [1.20-2.22],0.0017816373135908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",COL3A1,Collagen alpha-1(III) chain,17614,50,3.96 [1.48-10.65],0.0063226593605014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",COL4A1,Collagen alpha-1(IV) chain,20208,82,5.80 [4.03-8.36],3.881025482128029e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CORO6,Coronin-6,17030,52,2.20 [1.43-3.39],0.0003693417533937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",20108,81,1.57 [1.23-1.99],0.0002494524651123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CPA1,Carboxypeptidase A1,20456,83,0.51 [0.38-0.70],1.9584049089705083e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CPA2,Carboxypeptidase A2,20306,80,2.07 [1.58-2.71],1.3532015482438877e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CPB1,Carboxypeptidase B,20456,83,0.59 [0.42-0.83],0.0022040408703483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CPM,Carboxypeptidase M,20259,81,4.19 [2.63-6.68],1.7411040691599551e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CPVL,Probable serine carboxypeptidase CPVL,20342,81,2.96 [1.77-4.96],3.505201868281104e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CPXM2,Inactive carboxypeptidase-like protein X2,17610,52,5.90 [3.23-10.75],7.059369604750543e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CR1,Complement receptor type 1,17543,51,3.95 [2.03-7.69],5.510339659286988e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CR2,Complement receptor type 2,20332,82,2.68 [1.81-3.96],8.035293012405173e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CREG1,Protein CREG1,19961,78,0.41 [0.23-0.73],0.0023016856939343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRELD1,Protein disulfide isomerase CRELD1,17227,49,4.67 [2.39-9.12],6.435414588561529e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRELD2,Protein disulfide isomerase CRELD2,20254,80,2.30 [1.63-3.24],2.2320730815267624e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRH,Corticoliberin,19726,80,0.59 [0.46-0.75],3.1386322971125925e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRHBP,Corticotropin-releasing factor-binding protein,20198,79,8.55 [4.24-17.24],2.0363047014931416e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRIP2,Cysteine-rich protein 2,20021,81,2.86 [2.17-3.76],5.93661596474423e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRLF1,Cytokine receptor-like factor 1,20290,80,5.58 [2.82-11.03],7.693759059677846e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRTAC1,Cartilage acidic protein 1,20456,83,0.33 [0.19-0.59],0.0001919751854499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRTAM,Cytotoxic and regulatory T-cell molecule,20021,81,2.22 [1.56-3.17],9.120682921773052e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRYBB2,Beta-crystallin B2,17573,52,1.65 [1.44-1.90],2.2546833155882866e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CSF1R,Macrophage colony-stimulating factor 1 receptor,17611,51,3.05 [1.85-5.01],1.1523859373398643e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,20021,81,1.54 [1.17-2.01],0.0018639341515482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CSNK2A1,Casein kinase II subunit alpha,17572,52,2.29 [1.31-4.01],0.003547930006848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CSPG4,Chondroitin sulfate proteoglycan 4,17614,50,6.00 [2.87-12.57],1.9988048718563217e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CSRP3,Cysteine and glycine-rich protein 3,17001,51,1.38 [1.14-1.68],0.0011290327596183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CST5,Cystatin-D,19802,81,2.02 [1.46-2.81],2.416720109267063e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CST6,Cystatin-M,19667,81,2.91 [2.07-4.09],7.137840032676168e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CST7,Cystatin-F,20232,80,1.29 [1.11-1.51],0.0012494459268591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CSTB,Cystatin-B,19934,80,3.31 [2.33-4.71],2.2247156486639095e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTRB1,Chymotrypsinogen B,20222,80,0.46 [0.32-0.65],1.2088730577293805e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTRC,Chymotrypsin-C,20193,79,0.36 [0.27-0.47],1.4924508001660278e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTRL,Chymotrypsin-like protease CTRL-1,17573,52,0.34 [0.24-0.48],4.1027170534818944e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTSD,Cathepsin D,18945,80,2.10 [1.52-2.91],8.621546773090386e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTSE,Cathepsin E,17227,49,2.90 [1.78-4.71],1.727110087552613e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTSH,Pro-cathepsin H,19744,80,1.43 [1.11-1.85],0.0065041216515653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTSO,Cathepsin O,20408,82,7.05 [4.57-10.86],8.21745539641204e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTSS,Cathepsin S,15786,71,9.93 [4.63-21.32],3.875410079708902e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTSV,Cathepsin L2,20305,81,0.41 [0.25-0.67],0.0003825060815053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CX3CL1,Fractalkine,20021,81,4.98 [3.16-7.84],3.971773045029545e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CXADR,Coxsackievirus and adenovirus receptor,20157,80,2.52 [1.91-3.34],8.462811294862313e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CXCL14,C-X-C motif chemokine 14,19834,81,1.47 [1.21-1.78],7.850990019828166e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CXCL9,C-X-C motif chemokine 9,20290,80,1.74 [1.39-2.18],1.4083168200637438e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DAG1,Dystroglycan,20290,80,2.69 [1.77-4.10],3.973060740253999e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DAPK2,Death-associated protein kinase 2,17083,52,1.70 [1.24-2.34],0.0010166313999126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DBI,Acyl-CoA-binding protein,20137,80,1.76 [1.37-2.27],1.1912857636469852e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",20108,81,2.65 [1.92-3.67],3.956775308535818e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DDR1,Epithelial discoidin domain-containing receptor 1,20368,81,5.40 [3.00-9.72],1.9611418971726785e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DEFA1_DEFA1B,Neutrophil defensin 1,19836,82,2.10 [1.68-2.63],6.313997961338618e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DEFB103A_DEFB103B,Beta-defensin 103,16938,51,1.70 [1.20-2.42],0.0029264380797471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DEFB4A_DEFB4B,Beta-defensin 4A,19930,81,1.29 [1.14-1.47],9.058653714861612e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DKK3,Dickkopf-related protein 3,20456,83,3.90 [2.15-7.09],7.88509548211283e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DKK4,Dickkopf-related protein 4,19992,81,4.12 [3.26-5.20],1.5761000516528288e-32
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DLK1,Protein delta homolog 1,20456,83,2.57 [1.85-3.58],2.06988588049936e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DMD,Dystrophin,17158,52,1.90 [1.45-2.49],3.2357861035023504e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DMP1,Dentin matrix acidic phosphoprotein 1,17158,52,0.41 [0.31-0.53],1.340526733120938e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DNM3,Dynamin-3,17572,52,1.77 [1.25-2.50],0.0012850658578982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DNMBP,Dynamin-binding protein,20021,81,1.78 [1.36-2.33],2.204994343996793e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DPEP1,Dipeptidase 1,19988,80,1.72 [1.14-2.60],0.0093041102955048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DPP6,Dipeptidyl aminopeptidase-like protein 6,20108,81,7.97 [4.72-13.45],8.525389731958366e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DPY30,Protein dpy-30 homolog,20296,81,2.11 [1.71-2.60],2.6706645009152624e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DRAXIN,Draxin,20021,81,2.91 [2.04-4.15],4.214398206222495e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DSCAM,Down syndrome cell adhesion molecule,17572,52,3.55 [1.78-7.08],0.0003231269331625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DSG2,Desmoglein-2,20222,80,4.57 [2.37-8.80],5.539125370938422e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DSG3,Desmoglein-3,20294,80,3.90 [2.53-6.02],7.989247434043309e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DTNB,Dystrobrevin beta,17488,51,3.95 [2.84-5.47],2.0536780445894187e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DTX3,Probable E3 ubiquitin-protein ligase DTX3,20108,81,7.23 [4.76-10.96],1.3386222712442104e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",17522,52,1.63 [1.27-2.09],0.0001232328030879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EBI3_IL27,Interleukin-27,20337,81,4.47 [2.53-7.88],2.383254802851457e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EDA2R,Tumor necrosis factor receptor superfamily member 27,20371,81,8.44 [6.27-11.35],3.6775326931647296e-45
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,19823,80,2.90 [1.89-4.44],1.0363426618949225e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EDN1,Endothelin-1,17158,52,7.18 [3.45-14.95],1.4160277660288108e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EDNRB,Endothelin receptor type B,17083,52,1.76 [1.29-2.41],0.0004189070744721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EFCAB14,EF-hand calcium-binding domain-containing protein 14,17522,52,3.83 [2.51-5.86],5.232145772588429e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EFCAB2,Dynein regulatory complex protein 8,17281,52,2.24 [1.22-4.11],0.0095818548041961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EFHD1,EF-hand domain-containing protein D1,17572,52,2.62 [1.75-3.91],2.5097757843732624e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EFNA4,Ephrin-A4,19986,81,8.79 [6.34-12.21],1.317401092013547e-38
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EFNB2,Ephrin-B2,17117,51,1.85 [1.46-2.33],2.241951103766893e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EGFL7,Epidermal growth factor-like protein 7,19761,80,2.29 [1.62-3.25],2.943866906050008e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EGFLAM,Pikachurin,17522,52,2.77 [1.61-4.79],0.000255620981598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EGFR,Epidermal growth factor receptor,20456,83,0.18 [0.06-0.57],0.0034215519841393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ELN,Elastin,17610,52,6.78 [3.82-12.06],6.959994748134397e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ELOB,Elongin-B,17001,51,1.95 [1.42-2.68],3.6527888691527314e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ENAH,Protein enabled homolog,19834,81,2.07 [1.49-2.89],1.8117357155994347e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ENDOU,Poly(U)-specific endoribonuclease,16230,49,2.19 [1.53-3.15],2.045953346267034e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,19823,80,0.34 [0.15-0.77],0.0097479780530723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EPHA1,Ephrin type-A receptor 1,20265,80,8.93 [4.91-16.24],6.848433979740164e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EPHA2,Ephrin type-A receptor 2,19475,77,8.94 [6.09-13.12],4.3916187511776537e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EPHB6,Ephrin type-B receptor 6,19988,80,7.68 [4.77-12.36],4.7688044980785517e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EPO,Erythropoietin,20157,80,1.59 [1.34-1.89],1.388338143948845e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EPPK1,Epiplakin,17158,52,1.64 [1.22-2.22],0.0012392870273171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,20330,81,5.99 [3.91-9.19],2.3245899547544683e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ERBB3,Receptor tyrosine-protein kinase erbB-3,20142,79,0.27 [0.10-0.73],0.0099210370125139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ERBB4,Receptor tyrosine-protein kinase erbB-4,20289,81,3.11 [1.45-6.67],0.003560969856288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ERMAP,Erythroid membrane-associated protein,17083,52,3.64 [2.25-5.91],1.610528764375953e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ESYT2,Extended synaptotagmin-2,17573,52,1.69 [1.25-2.28],0.0007330983560678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",F10,Coagulation factor X,17611,51,0.31 [0.15-0.63],0.0011529867894487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",F11R,Junctional adhesion molecule A,20222,80,1.80 [1.30-2.50],0.0004513645404336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",F2R,Proteinase-activated receptor 1,20254,80,3.02 [2.13-4.28],5.069763375142836e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",F3,Tissue factor,20249,81,4.66 [2.48-8.75],1.645275732307467e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FABP1,"Fatty acid-binding protein, liver",20198,79,2.38 [2.02-2.81],6.69566373823611e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FABP2,"Fatty acid-binding protein, intestinal",20208,82,1.91 [1.56-2.35],7.302455292972236e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FABP3,"Fatty acid-binding protein, heart",17610,52,4.41 [3.28-5.95],1.547494605512128e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FABP4,"Fatty acid-binding protein, adipocyte",20456,83,3.16 [2.41-4.12],3.993259343899934e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FABP5,Fatty acid-binding protein 5,20290,81,1.71 [1.33-2.21],3.104262973716213e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FABP6,Gastrotropin,19785,80,1.66 [1.27-2.17],0.0002122957297188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FABP9,Fatty acid-binding protein 9,20157,80,1.80 [1.33-2.43],0.0001208685991194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FAM171B,Protein FAM171B,17526,51,2.23 [1.33-3.73],0.0022589699970544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FAM3D,Protein FAM3D,17522,52,3.38 [2.40-4.75],3.0398722226978135e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FAP,Prolyl endopeptidase FAP,20456,83,8.37 [4.20-16.69],1.6110662460092152e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FAS,Tumor necrosis factor receptor superfamily member 6,20398,83,2.29 [1.78-2.95],1.5833532330473666e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FBLN2,Fibulin-2,17614,50,7.21 [4.17-12.49],1.7192805300330392e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,17610,52,1.84 [1.32-2.56],0.000312630392965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FCAR,Immunoglobulin alpha Fc receptor,20157,80,2.22 [1.49-3.29],7.99144643889479e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,17572,52,3.88 [1.86-8.09],0.0003071289024048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FCER2,Low affinity immunoglobulin epsilon Fc receptor,20222,80,2.05 [1.68-2.50],1.2201995533843886e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,20155,82,2.18 [1.40-3.38],0.0005285651110572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FCN2,Ficolin-2,20160,82,0.51 [0.36-0.74],0.0003483867311269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FCRL2,Fc receptor-like protein 2,20298,82,1.83 [1.39-2.41],1.7001377255629546e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FCRL5,Fc receptor-like protein 5,20222,80,2.19 [1.66-2.88],2.366970652375574e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FCRL6,Fc receptor-like protein 6,20157,80,1.71 [1.29-2.28],0.0002365613861333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FCRLB,Fc receptor-like B,19761,80,1.51 [1.25-1.81],1.2293779482064116e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FDX1,"Adrenodoxin, mitochondrial",17001,51,1.54 [1.16-2.05],0.0028349881975711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FGF23,Fibroblast growth factor 23,20345,81,2.06 [1.69-2.52],1.0966444039339553e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FGF5,Fibroblast growth factor 5,19834,81,5.08 [3.41-7.56],1.3032913896361906e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FGFBP1,Fibroblast growth factor-binding protein 1,20289,81,0.10 [0.06-0.17],4.505014383890986e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FGFBP2,Fibroblast growth factor-binding protein 2,17614,50,0.20 [0.11-0.37],1.1453188485651653e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FGL1,Fibrinogen-like protein 1,17611,51,2.05 [1.41-2.98],0.0001724423619113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FLT1,Vascular endothelial growth factor receptor 1,20073,81,3.24 [1.76-5.96],0.000160863602946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FLT3LG,Fms-related tyrosine kinase 3 ligand,20408,82,2.22 [1.29-3.82],0.0038065777138425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FN1,Fibronectin,17637,50,0.16 [0.07-0.40],7.561785332898804e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FNDC1,Fibronectin type III domain-containing protein 1,17573,52,5.10 [2.99-8.70],2.138251076810952e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FOLR1,Folate receptor alpha,20204,81,5.55 [3.49-8.83],4.491507138112397e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FOLR2,Folate receptor beta,20368,81,6.03 [3.54-10.26],3.628013532350213e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FSTL3,Follistatin-related protein 3,20158,79,9.95 [6.79-14.60],6.65899345070275e-32
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FURIN,Furin,20289,81,0.34 [0.18-0.63],0.0006612296354988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,20368,81,2.17 [1.49-3.17],5.996739214933775e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,17158,52,1.79 [1.15-2.77],0.0096031780385639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,20108,81,2.70 [1.37-5.32],0.0041561576084428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,19834,81,1.83 [1.22-2.75],0.0034935212199367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,17610,52,3.28 [1.82-5.91],7.938260284373917e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GAS6,Growth arrest-specific protein 6,20344,83,7.11 [3.49-14.47],6.225563019988222e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GAST,Gastrin,17573,52,1.27 [1.09-1.48],0.0019058648525032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GC,Vitamin D-binding protein,17637,50,0.22 [0.07-0.69],0.0094280479775129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GCG,Pro-glucagon,19761,80,1.56 [1.33-1.83],4.246190091506472e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,16814,48,2.19 [1.64-2.94],1.3440165641244317e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",20108,81,4.00 [2.48-6.45],1.2909197996798376e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GDF15,Growth/differentiation factor 15,20456,83,8.86 [6.78-11.57],9.347832629003581e-58
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GDNF,Glial cell line-derived neurotrophic factor,19753,77,3.17 [2.33-4.33],3.0306375636681066e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GFRA2,GDNF family receptor alpha-2,20108,81,4.11 [2.07-8.19],5.61706291160906e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GFRA3,GDNF family receptor alpha-3,19966,81,4.97 [2.98-8.27],7.038798435795752e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GH1,Somatotropin,20167,82,1.17 [1.05-1.31],0.004708169502667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GHR,Growth hormone receptor,17227,49,0.16 [0.06-0.42],0.0001968674923158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GIP,Gastric inhibitory polypeptide,17158,52,2.20 [1.53-3.17],2.036319050922178e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GIPC2,PDZ domain-containing protein GIPC2,17573,52,6.33 [3.70-10.84],1.7694058745530767e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GM2A,Ganglioside GM2 activator,17161,48,2.39 [1.85-3.10],3.927102842403157e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GOLM2,Protein GOLM2,20368,81,3.83 [1.95-7.53],9.670432660490966e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GPA33,Cell surface A33 antigen,20108,81,0.80 [0.69-0.93],0.0027514505712208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GPHA2,Glycoprotein hormone alpha-2,17522,52,1.66 [1.16-2.39],0.0056809118834062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GPR37,Prosaposin receptor GPR37,19823,80,3.45 [2.67-4.46],3.621597163239241e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GRN,Progranulin,20125,80,4.57 [2.55-8.19],3.125855145212682e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GRPEL1,"GrpE protein homolog 1, mitochondrial",20108,81,1.69 [1.30-2.20],8.071813871364824e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GUCA2A,Guanylin,20113,80,7.48 [5.16-10.82],1.6758897134207834e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",20301,81,0.69 [0.53-0.92],0.0098683056959429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HAVCR1,Hepatitis A virus cellular receptor 1,20335,81,3.66 [3.01-4.44],2.4960288677022208e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HAVCR2,Hepatitis A virus cellular receptor 2,20222,80,6.42 [4.36-9.45],4.277705358088048e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HBZ,Hemoglobin subunit zeta,17610,52,0.68 [0.51-0.89],0.0061289617752816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HDGFL2,Hepatoma-derived growth factor-related protein 2,17573,52,1.64 [1.15-2.36],0.0070081412179512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HEG1,Protein HEG homolog 1,17227,49,4.04 [1.59-10.27],0.0034079847172796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HGF,Hepatocyte growth factor,20408,82,2.73 [1.76-4.26],8.319093915495367e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HIP1R,Huntingtin-interacting protein 1-related protein,17533,52,2.28 [1.78-2.92],9.276897949770415e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",17572,52,5.00 [2.16-11.55],0.0001671077913604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",20157,80,7.58 [4.99-11.52],2.2690711768868617e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HMBS,Porphobilinogen deaminase,20371,81,0.43 [0.28-0.66],0.0001009753918437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HMCN2,Hemicentin-2,17199,49,5.41 [3.28-8.92],3.6696450537360106e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HMOX1,Heme oxygenase 1,19972,81,0.29 [0.19-0.46],1.3191556900348194e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HNMT,Histamine N-methyltransferase,19919,80,2.97 [2.13-4.15],1.730002992644294e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,17572,52,1.74 [1.18-2.56],0.0048824254472416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HPGDS,Hematopoietic prostaglandin D synthase,19761,80,0.35 [0.20-0.60],0.0001342550366988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,17158,52,2.65 [1.86-3.78],6.405138460900668e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,20108,81,2.90 [1.80-4.67],1.229126160568511e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,17083,52,6.98 [4.46-10.92],1.9066511079292202e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HSBP1,Heat shock factor-binding protein 1,17158,52,1.73 [1.30-2.29],0.0001529585435257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,20157,80,0.36 [0.23-0.57],1.2130916334410002e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HSPA2,Heat shock-related 70 kDa protein 2,17526,51,3.07 [2.13-4.41],1.4955136950505463e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HSPB6,Heat shock protein beta-6,20371,81,8.85 [6.37-12.29],1.238913712772817e-38
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ICAM2,Intercellular adhesion molecule 2,20456,83,3.45 [1.84-6.47],0.0001122747055177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ICOSLG,ICOS ligand,20108,81,9.62 [3.65-25.35],4.66899583232909e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IDI2,Isopentenyl-diphosphate delta-isomerase 2,19753,77,2.34 [1.82-3.00],3.480649561498996e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IDUA,Alpha-L-iduronidase,20371,81,2.46 [1.56-3.89],0.0001122700179453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,17079,50,3.38 [2.11-5.41],3.921322428147921e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IFNL1,Interferon lambda-1,19753,77,1.75 [1.21-2.53],0.0027908966073465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,17614,50,9.40 [4.70-18.79],2.2501420282272856e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGF2R,Cation-independent mannose-6-phosphate receptor,20222,80,4.83 [2.11-11.06],0.0001957184086562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGFBP2,Insulin-like growth factor-binding protein 2,20433,83,4.60 [3.32-6.37],5.677116708764256e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGFBP3,Insulin-like growth factor-binding protein 3,20332,82,0.17 [0.11-0.26],7.419496450499933e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGFBP4,Insulin-like growth factor-binding protein 4,19953,77,5.07 [3.99-6.46],7.670380022139625e-40
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGFBP6,Insulin-like growth factor-binding protein 6,20145,82,8.54 [6.13-11.91],1.2439332651461115e-36
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGFBP7,Insulin-like growth factor-binding protein 7,20456,83,4.34 [3.07-6.12],6.412050724068875e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGFBPL1,Insulin-like growth factor-binding protein-like 1,20208,82,5.43 [3.55-8.30],5.671123908371741e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGLC2,Immunoglobulin lambda constant 2,17604,50,2.37 [1.57-3.56],3.6260052343288864e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGSF3,Immunoglobulin superfamily member 3,20108,81,2.47 [1.84-3.32],2.1382160798992147e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGSF8,Immunoglobulin superfamily member 8,20208,82,5.78 [3.71-9.00],8.768546356497904e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL10RB,Interleukin-10 receptor subunit beta,20290,80,8.15 [4.82-13.76],4.341082615187702e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL12A_IL12B,Interleukin-12,20108,81,1.94 [1.60-2.35],1.189345638352123e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL12B,Interleukin-12 subunit beta,20408,82,3.03 [2.22-4.13],3.3382774542293857e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL12RB1,Interleukin-12 receptor subunit beta-1,19834,81,3.42 [2.31-5.05],6.80732231344355e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL15,Interleukin-15,20157,80,2.92 [1.77-4.82],2.708697708614651e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL15RA,Interleukin-15 receptor subunit alpha,19834,81,6.41 [3.92-10.49],1.4709220784269625e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL16,Pro-interleukin-16,20408,82,2.38 [1.76-3.23],1.9902352829030825e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL17C,Interleukin-17C,19834,81,1.86 [1.57-2.20],4.5378281547199544e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL17D,Interleukin-17D,19834,81,1.77 [1.26-2.49],0.0010562396313673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL17RB,Interleukin-17 receptor B,19908,80,2.23 [1.55-3.21],1.4973361644009609e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL18,Interleukin-18,20136,79,1.79 [1.24-2.57],0.0018051058752266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL18BP,Interleukin-18-binding protein,20332,82,9.49 [6.27-14.37],2.102884842722924e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL18R1,Interleukin-18 receptor 1,20408,82,8.06 [4.85-13.40],8.776223767140955e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL19,Interleukin-19,19686,82,1.97 [1.62-2.40],1.8077814210149528e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL1RL1,Interleukin-1 receptor-like 1,20398,83,3.85 [2.63-5.62],3.206765532043209e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL1RN,Interleukin-1 receptor antagonist protein,20167,80,1.68 [1.27-2.21],0.0002290363614992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL22,Interleukin-22,17526,51,1.86 [1.44-2.42],2.9913498654424515e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL2RA,Interleukin-2 receptor subunit alpha,20050,81,3.71 [2.65-5.19],2.0355754732751124e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL33,Interleukin-33,19834,81,2.15 [1.29-3.57],0.0030951322110063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL36G,Interleukin-36 gamma,17001,52,1.45 [1.11-1.90],0.0058636162895888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL3RA,Interleukin-3 receptor subunit alpha,19834,81,2.14 [1.27-3.59],0.0041399688791298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL4R,Interleukin-4 receptor subunit alpha,20157,80,4.25 [3.17-5.71],6.061487693251918e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL5RA,Interleukin-5 receptor subunit alpha,20157,80,1.95 [1.48-2.58],2.4346153463985145e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL6,Interleukin-6,20108,81,1.38 [1.14-1.66],0.0008610512471976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL6R,Interleukin-6 receptor subunit alpha,20128,82,2.94 [1.66-5.20],0.0002212613787234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IMMT,MICOS complex subunit MIC60,17526,51,2.35 [1.68-3.29],5.937095399444124e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",INHBB,Inhibin beta B chain,17227,49,3.62 [2.51-5.23],6.719687443075536e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",INSL4,Early placenta insulin-like peptide,17526,51,1.73 [1.28-2.34],0.0003669419818636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITGA5,Integrin alpha-5,20222,80,3.28 [1.57-6.87],0.0015834721144144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITGB2,Integrin beta-2,20092,82,3.25 [1.74-6.07],0.0002073917801922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITGB6,Integrin beta-6,19834,81,5.39 [3.04-9.56],8.040694548249514e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITGB7,Integrin beta-7,20371,81,1.81 [1.24-2.63],0.0018665653385976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITGBL1,Integrin beta-like protein 1,17614,50,3.24 [2.05-5.13],4.942025794622798e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,20332,82,5.51 [3.29-9.21],7.976673490742254e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITM2A,Integral membrane protein 2A,20157,80,1.75 [1.29-2.39],0.0003939771219379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",JAM3,Junctional adhesion molecule C,17227,49,2.89 [1.92-4.35],3.561524737384882e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",JCHAIN,Immunoglobulin J chain,19834,81,1.73 [1.28-2.34],0.000364841021434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",JUN,Transcription factor AP-1,19834,81,1.80 [1.42-2.27],8.020203881737511e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,20108,81,3.61 [2.27-5.73],5.731908389196045e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KIAA0319,Dyslexia-associated protein KIAA0319,17573,52,2.60 [1.62-4.18],7.487439298207259e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KIAA1549,UPF0606 protein KIAA1549,17281,52,1.66 [1.24-2.22],0.0005761034018894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KIF1C,Kinesin-like protein KIF1C,17001,51,2.19 [1.55-3.09],7.321952049540122e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KITLG,Kit ligand,20208,82,2.45 [1.44-4.20],0.0010372036199711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLB,Beta-klotho,19753,77,1.43 [1.12-1.84],0.0045104632560358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLK10,Kallikrein-10,20228,81,1.75 [1.19-2.55],0.0040516176313972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLK11,Kallikrein-11,20105,80,3.58 [2.72-4.72],8.560263284959912e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLK4,Kallikrein-4,20371,81,3.82 [3.17-4.61],5.935659819431e-45
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLK6,Kallikrein-6,20249,81,7.76 [4.49-13.39],1.9464046127686254e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLK8,Kallikrein-8,19540,76,3.73 [2.58-5.41],3.454927641976795e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLKB1,Plasma kallikrein,17257,49,0.25 [0.09-0.66],0.0049283993446285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLRD1,Natural killer cells antigen CD94,20408,82,2.84 [1.91-4.22],2.193671320052645e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLRK1,NKG2-D type II integral membrane protein,17573,52,2.18 [1.46-3.26],0.0001497298977474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KRT18,"Keratin, type I cytoskeletal 18",20108,81,1.64 [1.36-1.98],2.0975992300270328e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KRT19,"Keratin, type I cytoskeletal 19",20117,80,2.37 [1.94-2.89],2.5178009252757964e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KRT8,"Keratin, type II cytoskeletal 8",17030,52,1.43 [1.20-1.71],7.712857058217566e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LAG3,Lymphocyte activation gene 3 protein,20108,81,3.31 [2.45-4.48],7.168766521905167e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,20198,79,4.67 [3.48-6.27],7.999181997339304e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,20021,81,1.39 [1.13-1.70],0.0016225745152204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LAMA4,Laminin subunit alpha-4,20290,80,4.66 [2.74-7.93],1.4618631381740976e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LAMP3,Lysosome-associated membrane glycoprotein 3,20379,82,1.77 [1.26-2.49],0.0009537890564812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LAYN,Layilin,19988,80,9.63 [6.95-13.33],2.885363507165793e-42
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LBP,Lipopolysaccharide-binding protein,20332,82,2.19 [1.62-2.96],4.0288571396246426e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LBR,Delta(14)-sterol reductase LBR,20368,81,1.47 [1.19-1.81],0.0003694079024667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LCAT,Phosphatidylcholine-sterol acyltransferase,17611,51,0.37 [0.19-0.72],0.0031882726753291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LCN15,Lipocalin-15,17572,52,1.81 [1.44-2.28],3.356487701338223e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LCN2,Neutrophil gelatinase-associated lipocalin,19660,82,4.68 [3.50-6.27],2.652368263183163e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LCP1,Plastin-2,17614,50,0.30 [0.15-0.59],0.000617662592856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LDLR,Low-density lipoprotein receptor,20257,82,0.59 [0.40-0.87],0.0072494367400006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LECT2,Leukocyte cell-derived chemotaxin-2,17610,52,1.78 [1.24-2.56],0.001929427364968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LETM1,Mitochondrial proton/calcium exchanger protein,17572,52,2.50 [1.85-3.40],3.8089899048489175e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LGALS1,Galectin-1,20208,82,5.40 [3.66-7.97],2.1288088564207426e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LGALS3,Galectin-3,20269,83,3.87 [2.29-6.55],4.184128854040292e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LGALS4,Galectin-4,20198,79,6.15 [4.69-8.06],2.2036435445770528e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LGALS7_LGALS7B,Galectin-7,20128,81,2.30 [1.74-3.05],5.315848940705911e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LGALS9,Galectin-9,20196,80,7.28 [4.63-11.46],9.623329388056697e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LGMN,Legumain,20290,80,3.21 [1.93-5.34],6.929060939736938e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,20167,82,5.23 [3.02-9.04],3.2160430017844434e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,17610,52,2.13 [1.44-3.16],0.0001648528652522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,20375,83,2.77 [1.53-5.04],0.0008269440326926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,19834,81,3.32 [2.30-4.81],1.8286125104526227e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LMNB2,Lamin-B2,17573,52,5.00 [3.05-8.21],1.8498845437019863e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LMOD1,Leiomodin-1,17572,52,3.73 [2.76-5.05],1.2622313198948732e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LONP1,"Lon protease homolog, mitochondrial",17158,52,1.51 [1.13-2.03],0.0058842107861114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LPL,Lipoprotein lipase,20208,82,0.63 [0.46-0.88],0.0062970481256513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LPO,Lactoperoxidase,19505,81,2.17 [1.65-2.85],2.420967941177388e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,20301,81,3.58 [2.16-5.94],7.819689434144332e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,17023,52,2.50 [1.37-4.55],0.0027432167778202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LRP11,Low-density lipoprotein receptor-related protein 11,20208,82,7.64 [4.99-11.70],8.628348825324626e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LRRC25,Leucine-rich repeat-containing protein 25,20108,81,1.85 [1.17-2.92],0.0087778867679216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LRRC38,Leucine-rich repeat-containing protein 38,17117,51,1.72 [1.14-2.60],0.0096162182884201
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LSP1,Lymphocyte-specific protein 1,20157,80,2.00 [1.29-3.12],0.0020114669147603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LTBP2,Latent-transforming growth factor beta-binding protein 2,20456,83,5.61 [3.64-8.65],5.181050687470217e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LTBP3,Latent-transforming growth factor beta-binding protein 3,19761,80,1.85 [1.45-2.36],8.628214240025837e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LUZP2,Leucine zipper protein 2,17526,51,2.07 [1.53-2.81],2.705249150851123e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LXN,Latexin,19942,81,0.57 [0.41-0.81],0.001374386842548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LY6D,Lymphocyte antigen 6D,20105,79,3.52 [2.63-4.72],3.734067634503544e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LY9,T-lymphocyte surface antigen Ly-9,19944,82,4.87 [2.93-8.09],9.307367309336351e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LY96,Lymphocyte antigen 96,20021,81,3.25 [2.23-4.75],9.710301204412982e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LYAR,Cell growth-regulating nucleolar protein,19761,80,0.38 [0.23-0.64],0.0002761744749895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LYPD3,Ly6/PLAUR domain-containing protein 3,20122,80,2.15 [1.31-3.53],0.0024839246890964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LYZL2,Lysozyme-like protein 2,16965,52,2.01 [1.19-3.40],0.0091627819255647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,19952,80,1.80 [1.46-2.21],2.664957844895374e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MAMDC2,MAM domain-containing protein 2,17610,52,7.19 [4.49-11.52],2.49867341145969e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MAMDC4,Apical endosomal glycoprotein,17526,51,0.47 [0.28-0.79],0.0044602029625728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MANSC1,MANSC domain-containing protein 1,20289,81,6.24 [3.59-10.83],7.999056829391502e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MAP2,Microtubule-associated protein 2,17573,52,1.96 [1.31-2.92],0.0009553148193635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MAPK13,Mitogen-activated protein kinase 13,16965,52,1.87 [1.30-2.69],0.000785395905775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MARCO,Macrophage receptor MARCO,20208,82,3.39 [1.64-6.98],0.0009442877777929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MATN2,Matrilin-2,20225,79,3.68 [1.99-6.79],3.0904695113934824e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MATN3,Matrilin-3,19986,81,0.41 [0.22-0.74],0.0032098917361996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MB,Myoglobin,20456,83,3.53 [2.81-4.44],4.456863026030025e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MCAM,Cell surface glycoprotein MUC18,20332,82,3.85 [2.31-6.44],2.519607395230113e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MCFD2,Multiple coagulation factor deficiency protein 2,20105,82,2.91 [1.90-4.45],9.387864485044184e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,20021,81,1.52 [1.15-2.02],0.0034606660200913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MDK,Midkine,20233,81,2.23 [1.84-2.71],6.075892969813496e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",17158,52,1.57 [1.19-2.08],0.001496252871841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MENT,Protein MENT,17227,49,0.22 [0.08-0.59],0.002694738199506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MERTK,Tyrosine-protein kinase Mer,20408,82,8.58 [4.79-15.37],5.0682891793835e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MFAP4,Microfibril-associated glycoprotein 4,17227,49,8.00 [3.70-17.31],1.298895748708751e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MFAP5,Microfibrillar-associated protein 5,20456,83,4.96 [3.21-7.68],6.516695171500015e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MFGE8,Lactadherin,20222,80,3.20 [2.12-4.82],2.6062866312797694e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MIA,Melanoma-derived growth regulatory protein,20289,81,1.85 [1.17-2.93],0.0086723130760095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MILR1,Allergin-1,19834,81,2.36 [1.70-3.29],3.00697829030187e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MLN,Promotilin,20157,80,1.81 [1.43-2.30],8.040656216297392e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MME,Neprilysin,20108,81,1.37 [1.09-1.71],0.006385001327662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MMP1,Interstitial collagenase,19460,80,1.47 [1.16-1.87],0.001445349103181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MMP10,Stromelysin-2,20144,79,2.42 [1.90-3.09],1.1332387829448618e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MMP12,Macrophage metalloelastase,20201,80,2.96 [2.24-3.91],3.18048587833919e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MMP13,Collagenase 3,19753,77,2.40 [1.34-4.32],0.003384493672294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MMP3,Stromelysin-1,20222,80,2.06 [1.55-2.75],7.150956754884742e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MMP7,Matrilysin,19792,80,5.46 [3.80-7.84],3.468290129659675e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MOG,Myelin-oligodendrocyte glycoprotein,20371,81,5.39 [3.27-8.87],3.9114481762036336e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MRC1,Macrophage mannose receptor 1,17611,51,5.10 [2.35-11.04],3.5832452326052704e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",17572,52,1.44 [1.10-1.89],0.0081805209104938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MSMB,Beta-microseminoprotein,20166,82,1.80 [1.40-2.30],3.5831041299248025e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MSR1,Macrophage scavenger receptor types I and II,20368,81,3.44 [2.38-4.96],4.0818193000284936e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MSTN,Growth/differentiation factor 8,19823,80,2.34 [1.71-3.21],1.3399837144588034e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MTDH,Protein LYRIC,17083,52,1.61 [1.23-2.12],0.0006308084600004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MTIF3,"Translation initiation factor IF-3, mitochondrial",17522,52,1.52 [1.14-2.03],0.0044994453257737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MUC13,Mucin-13,19753,77,4.55 [3.42-6.06],2.440663868157481e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MVK,Mevalonate kinase,19834,81,1.49 [1.19-1.86],0.0004587100953718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MYBPC1,"Myosin-binding protein C, slow-type",17610,52,2.36 [1.86-3.00],2.5084825479576738e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MYBPC2,"Myosin-binding protein C, fast-type",17158,52,1.75 [1.51-2.04],3.745662441890102e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",17001,51,2.09 [1.60-2.73],5.257274751593775e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MYL3,Myosin light chain 3,17158,52,2.09 [1.54-2.83],2.5526685680299414e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",17117,51,2.24 [1.76-2.85],4.739788070444849e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MYOM2,Myomesin-2,17001,51,2.19 [1.61-2.98],6.631407149655123e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MYOM3,Myomesin-3,17227,49,1.85 [1.42-2.40],4.409679693661436e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MZB1,Marginal zone B- and B1-cell-specific protein,20261,79,2.50 [1.84-3.39],4.103348945944999e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NCAM1,Neural cell adhesion molecule 1,20332,82,2.93 [1.61-5.31],0.000408289983404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NCAN,Neurocan core protein,20368,81,0.25 [0.16-0.40],5.562560721380278e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,17522,52,8.12 [5.19-12.70],4.2871861928825605e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NEB,Nebulin,17001,51,2.21 [1.54-3.17],1.5473590545613372e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NECTIN4,Nectin-4,20289,81,5.56 [4.09-7.55],5.3558398588028245e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NEFL,Neurofilament light polypeptide,19692,77,4.34 [3.39-5.57],6.0476122453861575e-31
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NELL1,Protein kinase C-binding protein NELL1,20289,81,0.18 [0.12-0.27],7.977807130312128e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NEO1,Neogenin,17572,52,3.20 [1.53-6.67],0.0019172705454051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",17522,52,1.49 [1.15-1.94],0.0025380119427386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NGFR,Tumor necrosis factor receptor superfamily member 16,17610,52,2.09 [1.23-3.54],0.0061139553815478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NGRN,Neugrin,17573,52,3.43 [1.94-6.09],2.404355307553124e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NHLRC3,NHL repeat-containing protein 3,16791,48,4.30 [1.88-9.80],0.0005273655896727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NOS1,"Nitric oxide synthase, brain",19753,77,3.58 [2.82-4.55],1.13394534446547e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NOS3,"Nitric oxide synthase, endothelial",19753,77,1.63 [1.29-2.06],3.566955045056568e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NOTCH1,Neurogenic locus notch homolog protein 1,20456,83,8.22 [2.75-24.51],0.0001584833954253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NOTCH2,Neurogenic locus notch homolog protein 2,17614,50,5.30 [2.20-12.76],0.0001995919172448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NOTCH3,Neurogenic locus notch homolog protein 3,20456,83,2.80 [1.65-4.76],0.0001411444015062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NPC2,NPC intracellular cholesterol transporter 2,17305,50,4.67 [3.28-6.63],8.691286014135985e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NPDC1,Neural proliferation differentiation and control protein 1,20208,82,6.44 [4.65-8.91],3.318679747076548e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NPPB,Natriuretic peptides B,19823,80,1.32 [1.15-1.53],9.568225801123412e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NPPC,C-type natriuretic peptide,20157,80,2.05 [1.58-2.66],6.657650475539343e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NPY,Pro-neuropeptide Y,20371,81,3.85 [2.74-5.41],6.941577371028816e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NRCAM,Neuronal cell adhesion molecule,20208,82,7.10 [4.45-11.32],1.768108916086631e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NRP2,Neuropilin-2,20222,80,2.24 [1.24-4.06],0.0078033506025709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NT5C1A,Cytosolic 5'-nucleotidase 1A,17573,52,2.57 [1.79-3.69],3.5794300386920745e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NTF3,Neurotrophin-3,20157,80,2.17 [1.42-3.31],0.0003485140713649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NTRK2,BDNF/NT-3 growth factors receptor,20208,82,6.63 [3.50-12.56],6.6672094517773274e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NTproBNP,N-terminal prohormone of brain natriuretic peptide,20208,82,1.73 [1.51-1.98],2.1324245184004548e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NUCB2,Nucleobindin-2,20329,81,4.74 [2.98-7.54],4.5132537758873906e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NUDT16,U8 snoRNA-decapping enzyme,17485,51,1.57 [1.17-2.10],0.0027229255470397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NXPH1,Neurexophilin-1,19753,77,1.75 [1.28-2.39],0.0004413016602417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NXPH3,Neurexophilin-3,17083,52,6.24 [2.98-13.09],1.2369976394291842e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OBP2B,Odorant-binding protein 2b,19957,81,1.71 [1.31-2.24],9.39143035565314e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OCLN,Occludin,17572,52,3.19 [2.27-4.48],2.3571576154139977e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OGFR,Opioid growth factor receptor,20108,81,2.22 [1.27-3.89],0.0053258606383893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OGN,Mimecan,20222,80,6.98 [5.12-9.52],8.727765426127595e-35
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OLFM4,Olfactomedin-4,16582,47,1.79 [1.41-2.28],1.8296174055156088e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OMG,Oligodendrocyte-myelin glycoprotein,20108,81,0.66 [0.49-0.88],0.0049287988921796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OPTC,Opticin,20108,81,1.54 [1.14-2.09],0.0048735302771257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OSCAR,Osteoclast-associated immunoglobulin-like receptor,20225,79,3.72 [2.12-6.52],4.411685785296079e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OTUD7B,OTU domain-containing protein 7B,17572,52,1.78 [1.18-2.70],0.0058910929747104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",17158,52,1.61 [1.12-2.31],0.0097501203374065
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",P4HB,Protein disulfide-isomerase,20126,80,2.21 [1.34-3.65],0.0018214695219042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PADI2,Protein-arginine deiminase type-2,19834,81,1.42 [1.13-1.78],0.0025014211640165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PAEP,Glycodelin,20021,81,1.30 [1.08-1.56],0.0049317441357635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,19823,80,1.73 [1.29-2.32],0.0002297346245837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PALM,Paralemmin-1,17422,52,5.05 [3.23-7.90],1.3978248248581332e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PALM2,Paralemmin-2,17573,52,4.74 [3.25-6.90],5.387144500565274e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PAM,Peptidyl-glycine alpha-amidating monooxygenase,20359,82,3.29 [1.54-7.00],0.0020365314797894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,17522,52,2.75 [1.64-4.61],0.000122508705769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PCDH1,Protocadherin-1,20346,82,4.05 [2.43-6.74],7.761972984975597e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PCDH17,Protocadherin-17,20208,82,3.17 [2.15-4.67],6.016226604344154e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PCDH7,Protocadherin-7,17522,52,2.48 [1.82-3.36],7.222663716940018e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PCDHB15,Protocadherin beta-15,17526,51,2.55 [1.65-3.95],2.5681470083891247e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PDCD1,Programmed cell death protein 1,20334,81,2.39 [1.78-3.21],7.023981409302264e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PDCD1LG2,Programmed cell death 1 ligand 2,20108,81,9.07 [5.82-14.15],2.149902302430861e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PDGFRB,Platelet-derived growth factor receptor beta,20456,83,2.25 [1.25-4.06],0.0069600875863584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PDIA3,Protein disulfide-isomerase A3,17227,49,3.81 [2.20-6.60],1.906057662191225e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,17083,52,2.33 [1.57-3.46],2.565938550781656e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PEAR1,Platelet endothelial aggregation receptor 1,20456,83,8.10 [3.55-18.48],6.823957400236766e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PENK,Proenkephalin-A,17227,49,4.21 [2.85-6.22],5.32214441312534e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PEPD,Xaa-Pro dipeptidase,17611,51,0.25 [0.10-0.63],0.0033709097202958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",17610,52,2.01 [1.26-3.21],0.003577501606413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PGLYRP1,Peptidoglycan recognition protein 1,20375,83,3.03 [2.25-4.06],1.7101942243943067e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PHLDB1,Pleckstrin homology-like domain family B member 1,17522,52,2.81 [1.87-4.24],7.765101095928057e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PI3,Elafin,19959,83,2.63 [2.12-3.27],2.767446956917237e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PIGR,Polymeric immunoglobulin receptor,19954,80,8.32 [5.44-12.73],1.5527798325538852e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PILRA,Paired immunoglobulin-like type 2 receptor alpha,20222,80,8.06 [5.23-12.42],2.8427773584881312e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PILRB,Paired immunoglobulin-like type 2 receptor beta,20208,82,5.31 [3.58-7.88],1.0720363581332374e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PKD2,Polycystin-2,17001,51,1.83 [1.28-2.61],0.0009054595982584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PKLR,Pyruvate kinase PKLR,20229,80,0.62 [0.45-0.86],0.0037705445780574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLA2G10,Group 10 secretory phospholipase A2,20021,81,2.27 [1.64-3.15],8.880794175665348e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLA2G15,Phospholipase A2 group XV,20289,81,2.92 [1.48-5.78],0.0020579270951984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLA2G1B,Phospholipase A2,20427,83,0.50 [0.33-0.76],0.0010571577327061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLA2G7,Platelet-activating factor acetylhydrolase,20222,80,0.11 [0.07-0.18],9.311445562316191e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLIN3,Perilipin-3,20208,82,3.14 [2.18-4.53],8.660193139098833e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLXDC1,Plexin domain-containing protein 1,19761,80,1.82 [1.21-2.72],0.0037044701558305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLXDC2,Plexin domain-containing protein 2,17573,52,2.86 [1.87-4.38],1.2289224200453178e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PNLIP,Pancreatic triacylglycerol lipase,17611,51,0.39 [0.26-0.58],2.9709409253032542e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PODXL2,Podocalyxin-like protein 2,20289,81,2.45 [1.35-4.45],0.0033677370910104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",POF1B,Protein POF1B,17083,52,2.62 [1.98-3.48],2.6444155552627983e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",20108,81,2.22 [1.65-2.98],1.0086175291642185e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PON1,Serum paraoxonase/arylesterase 1,17611,51,0.31 [0.17-0.55],6.405307476290055e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PON3,Serum paraoxonase/lactonase 3,20290,80,0.56 [0.40-0.79],0.0010718059828766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",POSTN,Periostin,17614,50,3.13 [1.85-5.28],1.931892874615085e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PPL,Periplakin,17083,52,2.26 [1.33-3.82],0.0024305397948382
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,17572,52,2.27 [1.52-3.38],5.694000851460119e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PPP1R9B,Neurabin-2,20408,82,1.34 [1.09-1.65],0.005703592744364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,17522,52,1.40 [1.14-1.73],0.0016252427539172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PPP3R1,Calcineurin subunit B type 1,20021,81,1.94 [1.21-3.10],0.0060502029907253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PPY,Pancreatic prohormone,20207,79,1.59 [1.33-1.90],3.291035936288657e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRCP,Lysosomal Pro-X carboxypeptidase,20345,83,3.99 [2.71-5.88],2.476963060136723e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",19834,81,1.46 [1.13-1.89],0.0038723712585284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PREB,Prolactin regulatory element-binding protein,19834,81,2.82 [1.88-4.22],4.731972018232824e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRG2,Bone marrow proteoglycan,17614,50,4.03 [2.63-6.17],1.4329756022435276e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,19834,81,1.68 [1.24-2.28],0.0008099362395342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRL,Prolactin,20368,81,1.53 [1.23-1.90],0.000158730695363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRND,Prion-like protein doppel,17573,52,2.71 [1.92-3.83],1.4536232654304996e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PROC,Vitamin K-dependent protein C,20287,82,0.24 [0.12-0.48],6.820661027714326e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PROK1,Prokineticin-1,20157,80,1.81 [1.43-2.29],9.105741427538408e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PROS1,Vitamin K-dependent protein S,17637,50,0.15 [0.06-0.35],1.2847588800371075e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRR4,Proline-rich protein 4,17092,48,1.67 [1.19-2.33],0.0029970298658731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRRT3,Proline-rich transmembrane protein 3,17158,52,4.16 [2.51-6.90],3.4876841847548943e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRSS27,Serine protease 27,20151,82,3.73 [2.42-5.76],2.6024505213634282e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRSS8,Prostasin,20126,80,6.12 [4.23-8.88],1.0777909182717857e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRTG,Protogenin,20371,81,5.58 [2.74-11.33],2.045750113857162e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PSAP,Prosaposin,17439,50,4.17 [2.84-6.13],3.0346883123100963e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PSG1,Pregnancy-specific beta-1-glycoprotein 1,20021,81,2.47 [1.98-3.07],5.675128985798509e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PSPN,Persephin,20157,80,1.49 [1.28-1.73],3.157127202155455e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTGES2,Prostaglandin E synthase 2,16958,51,1.92 [1.24-2.97],0.0034166995475779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,20157,80,2.02 [1.62-2.53],6.374764732123114e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTK7,Inactive tyrosine-protein kinase 7,19753,77,4.90 [3.28-7.32],8.663481804832111e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTPRF,Receptor-type tyrosine-protein phosphatase F,20456,83,4.44 [2.31-8.54],8.037567718418874e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,19959,80,6.84 [4.41-10.59],7.161318606250401e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTPRR,Receptor-type tyrosine-protein phosphatase R,17573,52,3.27 [1.95-5.49],7.464297108657688e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PXN,Paxillin,19753,77,1.61 [1.21-2.15],0.0010193930841025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PYY,Peptide YY,17001,51,1.93 [1.54-2.42],1.4816580644269806e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PZP,Pregnancy zone protein,17637,50,0.53 [0.34-0.83],0.0054732969472068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",QPCT,Glutaminyl-peptide cyclotransferase,20256,83,9.31 [5.92-14.65],5.2554479687482e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RAB44,Ras-related protein Rab-44,17526,51,1.70 [1.23-2.34],0.0012427007061095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RAB6A,Ras-related protein Rab-6A,20157,80,0.46 [0.30-0.70],0.0002773656623238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RARRES1,Retinoic acid receptor responder protein 1,19761,80,2.02 [1.51-2.70],1.7303718686738026e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RARRES2,Retinoic acid receptor responder protein 2,20359,83,2.36 [1.78-3.13],2.390433949030148e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RASSF2,Ras association domain-containing protein 2,19761,80,1.45 [1.15-1.82],0.0014258939701955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RBFOX3,RNA binding protein fox-1 homolog 3,17572,52,3.66 [2.78-4.82],2.18213188218938e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RBP2,Retinol-binding protein 2,20108,81,2.52 [2.01-3.16],1.409402714957534e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RBP5,Retinol-binding protein 5,20108,81,2.04 [1.52-2.73],1.700291969133772e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RBP7,Retinoid-binding protein 7,17522,52,2.06 [1.54-2.76],1.0722463078282405e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",REG1A,Lithostathine-1-alpha,20108,82,4.63 [3.75-5.73],1.23632431299124e-45
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",REG1B,Lithostathine-1-beta,20456,83,3.06 [2.49-3.77],5.020122184402264e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",REG3A,Regenerating islet-derived protein 3-alpha,20456,83,2.92 [2.35-3.63],4.94464624719518e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",REG4,Regenerating islet-derived protein 4,20225,79,7.46 [5.51-10.10],1.2460861218477908e-38
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RELT,Tumor necrosis factor receptor superfamily member 19L,20222,80,7.71 [5.27-11.28],6.681520421548496e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",REN,Renin,20208,82,3.65 [3.09-4.31],3.009035159288657e-52
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,20108,81,4.72 [2.94-7.60],1.5828364893464418e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RETN,Resistin,20164,81,3.72 [2.74-5.05],4.215168664873208e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RGMA,Repulsive guidance molecule A,20368,81,8.83 [5.01-15.54],4.5477536347787456e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,17227,49,1.88 [1.18-2.99],0.0078191930082422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RLN2,Prorelaxin H2,17194,49,1.83 [1.36-2.46],6.312256539833328e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RNASE1,Ribonuclease pancreatic,17611,51,5.00 [3.18-7.87],3.350943792931407e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RNASE10,Inactive ribonuclease-like protein 10,17158,52,2.16 [1.66-2.82],1.2104404925419454e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RNASE4,Ribonuclease 4,17010,50,4.87 [3.05-7.79],3.526770752405737e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RNASE6,Ribonuclease K6,17482,51,2.95 [2.21-3.93],1.3399313548369524e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RNF149,E3 ubiquitin-protein ligase RNF149,17158,52,4.93 [2.89-8.40],4.5514274696274825e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ROBO1,Roundabout homolog 1,20225,79,3.90 [2.06-7.37],2.7455359681498e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ROBO2,Roundabout homolog 2,20368,81,2.96 [1.48-5.92],0.0021597023188654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,20208,82,9.80 [5.75-16.71],5.102356911790444e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RSPO1,R-spondin-1,20021,81,2.69 [1.74-4.16],9.161667669301422e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RTBDN,Retbindin,20108,81,3.03 [2.03-4.52],6.355045733545251e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",17572,52,1.51 [1.14-2.01],0.0040339801949893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RTN4R,Reticulon-4 receptor,20371,81,5.83 [4.12-8.27],3.2623299646596e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",S100A13,Protein S100-A13,17083,52,2.14 [1.31-3.50],0.0023586744902258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",S100P,Protein S100-P,19823,80,1.95 [1.57-2.43],2.328328132021629e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SAT2,Thialysine N-epsilon-acetyltransferase,17281,52,1.46 [1.10-1.94],0.0081029382664409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCAMP3,Secretory carrier-associated membrane protein 3,20108,81,1.46 [1.16-1.83],0.0010214961772007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCARB2,Lysosome membrane protein 2,19651,81,7.57 [5.50-10.41],1.6812828381643288e-35
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCARF1,Scavenger receptor class F member 1,20456,83,3.60 [2.41-5.40],4.720129591036551e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCG3,Secretogranin-3,20225,79,2.83 [1.63-4.92],0.0002265588204997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCGB1A1,Uteroglobin,20209,80,4.39 [2.96-6.51],1.695720200940648e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCGN,Secretagogin,19834,81,4.68 [3.43-6.38],1.7520470215016902e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCN4B,Sodium channel subunit beta-4,17158,52,5.34 [3.45-8.25],5.0925937343621603e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCRG1,Scrapie-responsive protein 1,17610,52,4.80 [2.79-8.25],1.4379140102403386e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCT,Secretin,17117,51,2.17 [1.40-3.35],0.0005066339504724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SDC1,Syndecan-1,20208,82,2.68 [1.92-3.75],8.453954151778488e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SDC4,Syndecan-4,20208,82,0.57 [0.39-0.85],0.005234119377263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SDK2,Protein sidekick-2,17227,49,1.95 [1.24-3.08],0.0038618318470726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SEL1L,Protein sel-1 homolog 1,17158,52,3.03 [2.24-4.09],4.859190073784373e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SELE,E-selectin,20456,83,2.05 [1.39-3.03],0.0003114639275603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SELL,L-selectin,17637,50,0.23 [0.09-0.61],0.0033248457233442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SEMA3F,Semaphorin-3F,20208,82,9.62 [5.05-18.33],6.038226157314793e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SEMA7A,Semaphorin-7A,20398,83,3.48 [2.39-5.08],8.746718033848954e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SEPTIN8,Septin-8,17547,52,4.29 [2.81-6.56],1.509894107387851e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SERPINB6,Serpin B6,20303,81,1.65 [1.18-2.30],0.0032808451493535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SERPINB8,Serpin B8,20408,82,1.50 [1.19-1.88],0.0004783542655945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SERPINF1,Pigment epithelium-derived factor,17359,50,5.41 [2.56-11.45],9.971348521908192e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SERPINI2,Serpin I2,17522,52,0.41 [0.23-0.70],0.0012634334520558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SEZ6L,Seizure 6-like protein,20289,81,5.96 [3.41-10.39],3.2561914001242886e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SFRP1,Secreted frizzled-related protein 1,19957,81,2.57 [1.99-3.32],4.627416075030784e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SFRP4,Secreted frizzled-related protein 4,17227,49,9.99 [5.42-18.41],1.672299795850365e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SH3BP1,SH3 domain-binding protein 1,17522,52,1.74 [1.19-2.55],0.0039401525813921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SHBG,Sex hormone-binding globulin,17611,51,0.51 [0.33-0.79],0.0027270543492063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SHISA5,Protein shisa-5,17614,50,4.90 [3.30-7.27],2.7815029611890707e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIAE,Sialate O-acetylesterase,20254,81,2.12 [1.42-3.16],0.0002240275196563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIGLEC1,Sialoadhesin,20290,80,4.76 [3.43-6.59],8.091544391169417e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIGLEC10,Sialic acid-binding Ig-like lectin 10,20157,80,4.58 [3.18-6.60],2.8628404818846125e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIGLEC5,Sialic acid-binding Ig-like lectin 5,20222,80,1.36 [1.09-1.69],0.0056504952517314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIGLEC6,Sialic acid-binding Ig-like lectin 6,20371,81,4.01 [2.81-5.74],2.7849480328481963e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIGLEC7,Sialic acid-binding Ig-like lectin 7,20208,82,4.02 [2.14-7.54],1.469740964905626e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIGLEC8,Sialic acid-binding Ig-like lectin 8,17158,52,2.94 [1.73-4.99],6.477713673315019e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,20272,82,2.61 [1.69-4.04],1.585781426208799e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIRPB1,Signal-regulatory protein beta-1,20173,79,5.30 [3.82-7.35],1.598293172360338e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLAMF1,Signaling lymphocytic activation molecule,19834,81,2.77 [2.10-3.66],5.279962085056044e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLAMF6,SLAM family member 6,19761,80,1.81 [1.15-2.85],0.009879034598599
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLAMF7,SLAM family member 7,20157,80,2.16 [1.64-2.84],4.0967382512967264e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLAMF8,SLAM family member 8,19761,80,2.18 [1.53-3.11],1.503836188995625e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLC39A14,Zinc transporter ZIP14,19753,77,2.15 [1.46-3.16],0.0001062957153217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLC39A5,Zinc transporter ZIP5,20157,80,1.50 [1.17-1.92],0.0012859016800934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,17522,52,1.57 [1.15-2.13],0.004023483486911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLITRK2,SLIT and NTRK-like protein 2,20371,81,5.69 [3.68-8.80],5.099554244897345e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLITRK6,SLIT and NTRK-like protein 6,19823,80,3.25 [2.24-4.72],6.508868110007057e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLMAP,Sarcolemmal membrane-associated protein,17522,52,1.88 [1.42-2.49],9.296673812957686e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SMOC1,SPARC-related modular calcium-binding protein 1,20371,81,5.95 [3.92-9.03],6.228766820112545e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SMOC2,SPARC-related modular calcium-binding protein 2,20290,80,7.10 [5.16-9.78],2.9420615450813445e-33
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SMTN,Smoothelin,17548,52,1.47 [1.15-1.88],0.0019491399793586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SNAPIN,SNARE-associated protein Snapin,17572,52,0.51 [0.31-0.85],0.009943049805087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SNCG,Gamma-synuclein,20021,81,4.00 [3.06-5.22],2.6032171293008042e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",17158,52,2.48 [1.64-3.73],1.5171813702562637e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SNRPB2,U2 small nuclear ribonucleoprotein B'',17573,52,1.75 [1.34-2.30],4.529722384283047e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SNX9,Sorting nexin-9,20208,82,1.48 [1.12-1.94],0.0050244377697701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SORBS1,Sorbin and SH3 domain-containing protein 1,17572,52,1.94 [1.45-2.61],9.923205188932676e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SORCS2,VPS10 domain-containing receptor SorCS2,19761,80,6.76 [4.54-10.05],4.070555744392321e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SOST,Sclerostin,20167,82,5.34 [3.45-8.27],5.5202926917912527e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SOX9,Transcription factor SOX-9,17117,51,4.67 [1.87-11.61],0.0009352455308941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,17572,52,2.64 [1.77-3.96],2.364112184829596e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPARCL1,SPARC-like protein 1,20266,82,2.43 [1.64-3.60],9.46276157213599e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPINK1,Serine protease inhibitor Kazal-type 1,20222,80,5.09 [3.93-6.59],7.747256863631669e-35
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPINK2,Serine protease inhibitor Kazal-type 2,17227,49,3.72 [2.24-6.16],3.4225677326272685e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPINK4,Serine protease inhibitor Kazal-type 4,20157,80,3.62 [2.91-4.50],4.964594320839214e-31
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPINK5,Serine protease inhibitor Kazal-type 5,20222,80,4.28 [2.66-6.89],2.108580102098063e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPINK6,Serine protease inhibitor Kazal-type 6,20371,81,1.79 [1.22-2.61],0.0026863563875211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPINT1,Kunitz-type protease inhibitor 1,20160,80,2.55 [1.49-4.36],0.0005962409312075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPINT2,Kunitz-type protease inhibitor 2,20290,80,6.91 [4.47-10.67],2.9959286237474476e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPOCK1,Testican-1,20021,81,0.22 [0.10-0.47],0.0001353764970902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPON1,Spondin-1,20225,79,5.03 [3.47-7.30],1.6956644509822898e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPP1,Osteopontin,20433,83,2.91 [2.12-4.01],5.851961447123305e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPRR3,Small proline-rich protein 3,17573,52,1.55 [1.13-2.12],0.0066787605212176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPTLC1,Serine palmitoyltransferase 1,17573,52,1.78 [1.22-2.59],0.0026348690844948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SRPX,Sushi repeat-containing protein SRPX,17610,52,3.68 [2.05-6.60],1.2818362948224298e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",20108,81,1.73 [1.22-2.45],0.0020638226767877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",20456,83,3.48 [2.32-5.22],1.6420330208322314e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",STC1,Stanniocalcin-1,20368,81,3.18 [2.36-4.29],4.0743725153660894e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",STC2,Stanniocalcin-2,20196,78,6.73 [3.63-12.48],1.3836373322217756e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",STX16,Syntaxin-16,19761,80,1.54 [1.20-1.99],0.0007983920076539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",STX4,Syntaxin-4,20108,81,1.63 [1.30-2.04],1.7940322338580125e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",STX8,Syntaxin-8,20157,80,1.82 [1.29-2.57],0.0006580292789102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SUSD2,Sushi domain-containing protein 2,20222,80,2.15 [1.27-3.66],0.0044286493360246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SUSD4,Sushi domain-containing protein 4,17526,51,1.99 [1.30-3.06],0.0015673142548815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SUSD5,Sushi domain-containing protein 5,17124,49,5.50 [2.77-10.93],1.0803073544698278e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SYT1,Synaptotagmin-1,17573,52,1.69 [1.16-2.46],0.0064574323662443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TACSTD2,Tumor-associated calcium signal transducer 2,17845,70,2.28 [1.47-3.56],0.0002546870700594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TAFA5,Chemokine-like protein TAFA-5,20108,81,7.33 [5.24-10.25],2.312779907947597e-31
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TCN2,Transcobalamin-2,20433,83,4.56 [3.23-6.44],6.754339165510517e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TEX101,Testis-expressed protein 101,17117,51,2.02 [1.52-2.68],1.0715420740298109e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TFF1,Trefoil factor 1,20116,80,2.35 [1.97-2.80],1.629866894862857e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TFF2,Trefoil factor 2,20254,80,4.09 [3.15-5.33],9.508439917716794e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TFF3,Trefoil factor 3,20226,83,3.51 [2.82-4.37],2.8405210814753304e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TFPI2,Tissue factor pathway inhibitor 2,20235,81,1.63 [1.23-2.15],0.0006475486874629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TFRC,Transferrin receptor protein 1,20322,83,2.01 [1.27-3.19],0.0028715937412711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TGFA,Protransforming growth factor alpha,20157,80,2.84 [2.08-3.87],5.6847053923088554e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TGFB1,Transforming growth factor beta-1 proprotein,20379,82,2.82 [1.95-4.07],3.5885097169587776e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TGFBR1,TGF-beta receptor type-1,17083,52,3.25 [1.75-6.04],0.0001832013900106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TGFBR2,TGF-beta receptor type-2,20289,81,6.75 [5.00-9.13],1.9797160438490823e-35
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TGFBR3,Transforming growth factor beta receptor type 3,20456,83,4.94 [2.88-8.47],6.343711618725871e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",THBD,Thrombomodulin,20208,82,7.93 [4.95-12.73],9.055639121450077e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",THBS2,Thrombospondin-2,20222,80,2.85 [2.03-4.01],1.6337176016124e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",THBS4,Thrombospondin-4,20250,82,3.43 [2.31-5.08],9.074985370133132e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",THOP1,Thimet oligopeptidase,20092,82,0.26 [0.13-0.52],0.0001162550980424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",THY1,Thy-1 membrane glycoprotein,20368,81,9.15 [5.72-14.65],3.009471548661854e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,17281,52,2.27 [1.44-3.57],0.0003993612714876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TIMP1,Metalloproteinase inhibitor 1,20036,82,7.96 [5.00-12.66],1.916736451236976e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TIMP2,Metalloproteinase inhibitor 2,17610,52,2.15 [1.53-3.01],8.698246852702783e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TINAGL1,Tubulointerstitial nephritis antigen-like,20137,82,5.47 [2.40-12.47],5.409865079037218e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TMOD4,Tropomodulin-4,16965,52,1.95 [1.19-3.18],0.0076255946577414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TMPRSS11D,Transmembrane protease serine 11D,17547,52,2.16 [1.44-3.23],0.0001879487990282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TMPRSS15,Enteropeptidase,20108,81,1.70 [1.37-2.11],1.576826906785537e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TMSB10,Thymosin beta-10,20222,80,1.91 [1.47-2.49],1.5331089713222825e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNF,Tumor necrosis factor,19796,79,1.91 [1.45-2.52],3.745417919822156e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,17522,52,1.88 [1.25-2.84],0.0024400316958996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,20021,81,5.27 [3.67-7.56],2.3137856163400304e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,20021,81,1.93 [1.68-2.22],7.808001462769766e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,20408,82,9.50 [7.01-12.89],1.556157521287342e-47
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,20198,79,7.29 [4.32-12.30],9.664194969934029e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,20289,81,7.51 [5.33-10.59],1.356434774049232e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,20225,79,2.98 [2.32-3.82],8.275380865403421e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,19834,81,2.09 [1.48-2.95],2.5189155298323865e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,17227,49,3.73 [2.28-6.09],1.426336739718444e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,20371,81,7.57 [5.53-10.35],1.0880469318844658e-36
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,20222,80,2.72 [2.23-3.33],9.089587913872044e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,20368,81,7.55 [4.63-12.32],5.828794992183262e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,20379,82,5.53 [4.07-7.52],1.1886586265686194e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,20021,81,2.22 [1.79-2.76],5.405995093660389e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,20368,81,2.32 [1.70-3.16],9.312008546036086e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,20021,81,3.18 [2.56-3.96],3.4143271948530443e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFSF12,Tumor necrosis factor ligand superfamily member 12,20408,82,0.26 [0.13-0.52],0.0001287901678406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFSF8,Tumor necrosis factor ligand superfamily member 8,17614,50,3.17 [1.89-5.30],1.1362632696161434e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNNI3,"Troponin I, cardiac muscle",19823,80,1.41 [1.09-1.82],0.008640783446947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNR,Tenascin-R,20021,81,2.34 [1.56-3.49],3.4829204487787016e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,17610,52,1.65 [1.22-2.24],0.0011789712622305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TOP2B,DNA topoisomerase 2-beta,17083,52,1.50 [1.10-2.04],0.0094872005252293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TPP1,Tripeptidyl-peptidase 1,20056,79,1.91 [1.37-2.65],0.0001284517069601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TPR,Nucleoprotein TPR,17001,51,1.57 [1.14-2.16],0.0052225736212637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TPSAB1,Tryptase alpha/beta-1,20376,82,2.25 [1.53-3.31],3.973092189465098e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TREML2,Trem-like transcript 2 protein,20222,80,2.91 [1.87-4.52],2.1690038569667567e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TRIAP1,TP53-regulated inhibitor of apoptosis 1,20371,81,1.89 [1.41-2.55],2.544641635414368e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TSC22D1,TSC22 domain family protein 1,17572,52,1.50 [1.11-2.03],0.0092254296140131
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TSPAN1,Tetraspanin-1,19823,80,1.34 [1.11-1.63],0.0027297685478531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TTN,Titin,17001,51,1.59 [1.20-2.12],0.0013794314451711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TTR,Transthyretin,17446,50,0.18 [0.07-0.47],0.0004201546888509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TXNDC5,Thioredoxin domain-containing protein 5,20368,81,1.84 [1.40-2.42],1.070003274993031e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",17083,52,2.04 [1.31-3.17],0.0015278695145752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,17610,52,1.91 [1.27-2.87],0.0018182444372576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ULBP2,UL16-binding protein 2,20021,81,6.04 [4.36-8.37],2.6603637520491398e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",UMOD,Uromodulin,20405,81,0.26 [0.20-0.34],3.97174016587737e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",UNC5D,Netrin receptor UNC5D,17083,52,3.12 [1.61-6.05],0.0007713028046704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",UPK3A,Uroplakin-3a,17030,52,0.42 [0.23-0.76],0.004127527683635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",USP28,Ubiquitin carboxyl-terminal hydrolase 28,17573,52,2.44 [1.76-3.39],8.875243076009213e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VCAM1,Vascular cell adhesion protein 1,20287,82,8.43 [4.99-14.23],1.506509627767694e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VEGFA,Vascular endothelial growth factor A,20345,82,1.58 [1.16-2.15],0.0040511265239228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VEGFD,Vascular endothelial growth factor D,20376,82,5.71 [3.41-9.55],3.284239173084173e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VIT,Vitrin,17610,52,4.63 [2.85-7.52],6.364044002052759e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VMO1,Vitelline membrane outer layer protein 1 homolog,20108,81,2.57 [1.89-3.49],1.6635077402244787e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VSIG2,V-set and immunoglobulin domain-containing protein 2,17526,51,2.69 [2.02-3.56],7.855393537106323e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VSIG4,V-set and immunoglobulin domain-containing protein 4,20196,78,6.71 [4.95-9.11],2.5545679959600682e-34
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,20172,82,1.54 [1.17-2.03],0.0020656994021001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VSTM1,V-set and transmembrane domain-containing protein 1,19753,77,1.57 [1.13-2.18],0.0078543185164477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,19823,80,1.57 [1.27-1.94],3.151343567321573e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",WFDC1,WAP four-disulfide core domain protein 1,17162,48,1.54 [1.22-1.95],0.000327261852803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",WFDC12,WAP four-disulfide core domain protein 12,20342,81,1.92 [1.50-2.46],2.6589872092761186e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",WFDC2,WAP four-disulfide core domain protein 2,19211,78,4.41 [3.41-5.71],2.526598246278496e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",20225,79,2.40 [1.38-4.16],0.0018717408725207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",WIF1,Wnt inhibitory factor 1,20371,81,0.34 [0.20-0.60],0.0001595666668536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",WNT9A,Protein Wnt-9a,19834,81,9.55 [6.25-14.58],1.5089330167407598e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",XCL1,Lymphotactin,20371,81,1.87 [1.51-2.31],8.436476094121024e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",XG,Glycoprotein Xg,20369,83,4.81 [3.41-6.79],3.3341169971565934e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",XPNPEP2,Xaa-Pro aminopeptidase 2,20289,81,0.63 [0.53-0.75],3.608114110854028e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",YAP1,Transcriptional coactivator YAP1,17573,52,9.07 [5.69-14.44],1.5562888409322148e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ZBTB17,Zinc finger and BTB domain-containing protein 17,19823,80,1.84 [1.39-2.44],1.889238874788616e-05
